Fund moves
27.8%Stake
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 18, 2026 · Filed Nov 18, 2026
An Anaptysbio director paid $6.43M out of pocket for Anaptysbio shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$6,427,111
Shares × reported transaction price
$1M+
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 5 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
6 days after results of Nov 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $47.06 on Nov 18, 2026, 27% above its 52-week low and 33% below its high, after a 3% rise over the previous 30 trading days
52-week range $37.01 (Nov 19, 2025) to $70.22 (Apr 14, 2026), 30% of the way up, from 250 adjusted closes. 30 trading days earlier: $45.65 on Oct 7, 2026. Describes the past only, not a forecast
RSI 47, 17% under its 200-day average, 4% under its 50-day average, 33% below the 52-week high, 20-day volatility 35% a year, against the S&P 500: +9 points over 1 month, −16 points over 3 months, −21 points over 6 months
From the adjusted closes up to Nov 18, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Fund moves
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Insider buying
Traded Nov 17 · filed 1 day later
An Anaptysbio director paid $6.96M out of pocket for Anaptysbio shares.
Insider buying
First insider buy since Jan 2025Traded Nov 16 · filed 2 days later
An Anaptysbio director paid $3.84M out of pocket for Anaptysbio shares. It was the first purchase in 22 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
EcoR1 Capital, LLC, Director's past purchases, 90 days after disclosure: 15 buys, median −8.0 pts vs S&P 500, beat it 2 of 15 times. Past results, not a forecast.